a phase i/ii trial of fixed-dose stereotactic body radiotherapy
1-1-phase diagramm
h2ax phosphorylation within the g1 phase after uv
electrical and magnetic properties near the magnetic phase
bortezomib-mediated downregulation of s-phase kinase protein-2